Capula Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$716K Buy
25,500
+12,700
+99% +$338K 0.01% 432
2025
Q4
$319K Sell
12,800
-18,000
-58% -$454K ﹤0.01% 476
2025
Q3
$785K Buy
30,800
+23,200
+305% +$573K ﹤0.01% 386
2025
Q2
$184K Sell
7,600
-1,300
-15% -$30.3K ﹤0.01% 388
2025
Q1
$226K Buy
+8,900
New +$233K ﹤0.01% 495
2024
Q3
Sell
-11,700
Closed -$327K 604
2024
Q2
$327K Buy
+11,700
New +$322K ﹤0.01% 359
2023
Q4
Sell
-22,100
Closed -$733K 518
2023
Q3
$733K Buy
+22,100
New +$782K 0.02% 277
2023
Q2
Sell
-594,800
Closed -$24.3M 702
2023
Q1
$24.3M Buy
594,800
+289,800
+95% +$12.5M 0.29% 67
2022
Q4
$15.6M Sell
305,000
-145,400
-32% -$6.97M 0.21% 129
2022
Q3
$19.7M Buy
450,400
+156,000
+53% +$7.58M 0.27% 107
2022
Q2
$15.4M Buy
294,400
+187,800
+176% +$9.57M 0.26% 102
2022
Q1
$5.52M Buy
+106,600
New +$5.53M 0.08% 178
2021
Q3
Sell
-18,600
Closed -$722K 1009
2021
Q2
$722K Buy
18,600
+16,100
+644% +$626K 0.01% 403
2021
Q1
$91K Buy
+2,500
New +$88.8K ﹤0.01% 457
2020
Q3
Sell
-158,205
Closed -$4.91M 280
2020
Q2
$4.91M Sell
158,205
-131,750
-45% -$4.48M 0.17% 130
2020
Q1
$8.98M Buy
289,955
+184,450
+175% +$6.29M 0.32% 95
2019
Q4
$3.92M Buy
+105,505
New +$3.76M 0.08% 196

Other funds holding PFE

Capula Management's PFE Position: Q1 2026 in Review

Capula Management reduced its Pfizer (PFE) stake by 86% in Q1 2026, selling an estimated $148K and leaving 929 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Capula Management first reported a position in PFE in Q1 2020 and has held it in 17 quarters since. The position peaked at $9.97M in Q2 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Capula Management held 929 shares of Pfizer worth $26.1K as of Q1 2026.
  • Capula Management sold 5,543 Pfizer shares in Q1 2026, an estimated $148K.
  • Pfizer made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1030 holding.
  • Capula Management first reported a position in Pfizer in Q1 2020 and has held it in 17 quarters since.
  • Capula Management's Pfizer position peaked at $9.97M in Q2 2020.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.